IL17A and bronchiectasis: IL-17, a central mediator of the Th17 pathway lacks correlation with bronchiectasis disease phenotypes suggestive of the more prominent role that neutrophil-mediated inflammation likely plays in the pathogenesis of bronchiectasis [94].